FDA Authorizes Pfizer Covid-19 Vaccine for Children 5-11By Radiant Health
Published: October 31, 2021
The FDA has authorized Pfizer’s COVID-19 vaccine for children ages 5 to 11. The children’s dose is one-third (10mcg) of that given to teens and adults and would be administered in two doses, three weeks apart. Vaccination for this age group is anticipated to begin as early as next week. Moderna said last week that a low dose of its vaccine is effective in children 6-11 and could be available in a few weeks. However, the company is yet to submit its data to the FDA for review.
Like what you're reading? Sign up for our free newsletter and never miss a post! Plus get a FREE digital version of our Issue No.10 with sign up.
- Kool-Aid And Other Sweet Drinks Recalled for Glass and Metal Pieces - November 28, 2021
- Covid-19 Cases in Children Spike Dramatically - November 28, 2021
- Omicron, A New Coronavirus Variant, Fuels Concerns Worldwide - November 28, 2021
- Major Pharmacies in Ohio to Pay for Opioid Crisis - November 28, 2021
- White Chocolate Bark with Okra, Raspberries, and Papaya - November 21, 2021
- The FDA Expands Covid-19 Vaccine Booster Dose for All Adults - November 21, 2021
- U.S. Drug Overdoses Rose Sharply Last Year - November 21, 2021
- Epidemiologists Warn of Covid-19 Winter Surge - November 21, 2021
- Pfizer’s Antiviral Pill Will Be Sold to Dozens of Poor Nations at a Discount - November 21, 2021
- Breathwork: How To Reduce Stress With Breathing Exercises - November 13, 2021